TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
10x Genomics Sweden AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
24,112
|
23,030
|
15,565 |
Financial expenses |
28
|
1
![]() |
1 |
Earnings before taxes |
13,864
|
12,206
|
7,371 |
EBITDA |
14,725
|
13,062
|
7,645 |
Total assets |
33,366
|
23,400
|
13,263 |
Current assets |
31,650
|
20,864
|
10,610 |
Current liabilities |
3,177
|
5,051
|
3,830 |
Equity capital |
30,190
|
18,349
|
9,432 |
- share capital |
5
|
4
|
5 |
Employees (average) |
39
|
45
|
38 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.5%
|
78.4%
|
71.1% |
Turnover per employee |
618
|
512
|
410 |
Profit as a percentage of turnover |
57.5%
|
53.0%
|
47.4% |
Return on assets (ROA) |
41.6%
|
52.2%
|
55.6% |
Current ratio |
996.2%
|
413.1%
|
277.0% |
Return on equity (ROE) |
45.9%
|
66.5%
|
78.1% |
Change turnover |
1,015
|
8,726
|
7,976 |
Change turnover % |
4%
|
61%
|
105% |
Chg. No. of employees |
-6
|
7
|
18 |
Chg. No. of employees % |
-13%
|
18%
|
90% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.